Krka Allowed to Market its Zyllt Drug in Poland
Novo mesto, 28 August - The Warsaw District Court has rejected the motion of the French pharma company Sanofi Pharma BristolMyers Squibb SNC for temporal injunction regarding the sale of drug Zyllt in Poland, manufactured by Slovenian pharma company Krka.
The rest of this news item is available to subscribers.
The news item consists of 397 characters (without spaces) or 78 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.